Skip to main content Skip to footer Skip to navigation

News & Insights

CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany

CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany

Interview TENGABLEs CEO Shai Feinsod

Interview TENGABLEs CEO Shai Feinsod

CorTec Welcomes Dr. Frank Desiere as Chief Executive Officer

CorTec Welcomes Dr. Frank Desiere as Chief Executive Officer

Marking a New Era in Medical Device Development – CorTec Announces Strategic Partnership with US-based Heraeus Medevio

Marking a New Era in Medical Device Development – CorTec Announces Strategic Partnership with US-based Heraeus Medevio

Next Important Milestone Reached for First-in-Human Implantation of the CorTec Brain Interchange™ System as a Therapeutic Brain-Computer Interface

CorTec has announced today that Institutional Review Board from University of Washington (IRB) has approved the Feasibility study for …

FDA approves Investigational Device Exemption for Early Feasibility Study for rehabilitation of stroke patients

CorTec has announced today that the US Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) …

Press Release: CorTec ready for next phase with Brain Interchange™ System

Press Release: CorTec ready for next phase with Brain Interchange™ System

The Brain Interchange™ System for Stroke Rehabilitation

The Brain Interchange™ System for Stroke Rehabilitation

A Software Interface for Developing Next Generation Neurotherapies

A Software Interface for Developing Next Generation Neurotherapies

© 2026 CorTec GmbH